George Richenberg PhD thesis - Supplementary table 6.14: Summary statistics for sfFDR-identified novel genome-wide significant (FP<5x10-8), independent lead variants associated with overall (inc), overall (exc), DNMT3A-, TET2- and ASXL1-mutant CH compared with mosaic chromosomal alterations (mCA), mosaic loss of chromosome X (mLOX) and mosaic loss of chromosome Y (mLOY)

Summary statistics for sfFDR-identified novel genome-wide significant (FP<5x10-8), independent lead variants associated with CH risk (25,657 cases and 342,869 controls) in indiviudals of European ancestry. These variants are compared with summary statistics for the risk of acquiring haematopoietic mCA (10,753 cases; 353,621 controls), mLOX (10,536 cases; 211,668 controls) and mLOY (35,406 cases; 141,737 controls) from GWAS of individuals of European ancestry in the UK Biobank (PMID: 36450978).